OtherReview Article
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
David Vaudry, Anthony Falluel-Morel, Steve Bourgault, Magali Basille, Delphine Burel, Olivier Wurtz, Alain Fournier, Billy K. C. Chow, Hitoshi Hashimoto, Ludovic Galas and Hubert Vaudry
Pharmacological Reviews September 2009, 61 (3) 283-357; DOI: https://doi.org/10.1124/pr.109.001370
David Vaudry
Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)
Anthony Falluel-Morel
Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)
Steve Bourgault
Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)
Magali Basille
Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)
Delphine Burel
Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)
Olivier Wurtz
Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)
Alain Fournier
Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)
Billy K. C. Chow
Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)
Hitoshi Hashimoto
Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)
Ludovic Galas
Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)
Hubert Vaudry
Institut National de la Santé et de la Recherche Médicale U413, European Institute for Peptide Research (Institut Fédératif de Recherches Multidisciplinaires sur les Peptides 23), Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); EA4310, University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., H.V.); INRS-Institut Armand-Frappier, Institut National de la Recherche Scientifique, Laval, Québec, Canada (S.B., A.F.); International Laboratory Samuel de Champlain (D.V., A.F.-M., S.B., M.B., D.B., O.W., A.F., H.V.); School of Biological Sciences, the University of Hong Kong, Pokfulam, Hong Kong (B.K.C.C.); Laboratory of Molecular Neuropharmacology, Graduate School of Pharmaceutical Sciences (H.H.), the Osaka-Hamamatsu Joint Research Center for Child Mental Development, Graduate School of Medicine (H.H.), and United Graduate School of Child Development, Osaka University, Kanazawa University, and Hamamatsu University School of Medicine, Osaka, Japan (H.H.); and Regional Platform for Cell Imaging (PRIMACEN), University of Rouen, Mont-Saint-Aignan, France (D.V., A.F.-M., S.B., M.B., D.B., O.W., L.G., H.V.)
PharmRev articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|
Log in using your username and password
Purchase access
You may purchase access to this article. This will require you to create an account if you don't already have one.
In this issue
OtherReview Article
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
David Vaudry, Anthony Falluel-Morel, Steve Bourgault, Magali Basille, Delphine Burel, Olivier Wurtz, Alain Fournier, Billy K. C. Chow, Hitoshi Hashimoto, Ludovic Galas and Hubert Vaudry
Pharmacological Reviews September 1, 2009, 61 (3) 283-357; DOI: https://doi.org/10.1124/pr.109.001370
OtherReview Article
Pituitary Adenylate Cyclase-Activating Polypeptide and Its Receptors: 20 Years after the Discovery
David Vaudry, Anthony Falluel-Morel, Steve Bourgault, Magali Basille, Delphine Burel, Olivier Wurtz, Alain Fournier, Billy K. C. Chow, Hitoshi Hashimoto, Ludovic Galas and Hubert Vaudry
Pharmacological Reviews September 1, 2009, 61 (3) 283-357; DOI: https://doi.org/10.1124/pr.109.001370
Jump to section
Related Articles
Cited By...
More in this TOC Section
Similar Articles
Advertisement